Funded Tech Companies
Graphite Bio
Graphite Bio, based in San Francisco, received equity investments through Fidelity Management & Research Company, OrbiMed and Deerfield Capital.
Company Overview
Company Name
Graphite Bio
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
279 E. Grand Ave. 430
San Francisco, CA 94025
USA
San Francisco, CA 94025
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Graphite Bio is a next-generation gene editing company focused on targeted DNA integration to precisely insert genetic payloads to treat a broad range of severe diseases. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, and is backed by Versant Ventures and Samsara BioCapital.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/25/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josh Lehrer
Chief Operating Officer
Katherine Stultz
VP - Bus. Development
Philip Gutry
Company Investors
- Fidelity Management & Research Company
- OrbiMed
- Deerfield Capital
- Venrock
- Rock Springs Capital (David Gardner)
- Logos Capital
- Samsara BioCapital (Abe Bassan)
- Versant Ventures (Jerel Davis)
- RA Capital (Jake Simson)
- Cormorant Asset Management
- Perceptive Advisors
- Janus Henderson Investors
- Surveyor Capital
- Federated Kaufmann Funds
Browse more funded tech companies:
Graphite | Graphite by Screenplay Studios
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs